| S8489 |
GSK180736A (GSK180736)
|
GSK180736A (GSK180736), developed as a Rho-associated, coiled-coil-containing protein kinase inhibitor, binds to GRK2(G protein-coupled receptor kinase 2) with logIC50 pf -6.6 (logIC50 -4.0 for GRK5 and >-3 for GRK1); ≥400-fold selective for GRK2 over both GRK1 and GRK5.
|
-
Cell Rep, 2023, 42(7):112812
-
Cancer Lett, 2022, 529:112-125
|
|
| S6621 |
CCG215022
|
CCG215022 serves as a pan-G protein-coupled receptor kinases (GRKs) inhibitor with IC50 of 3.9 μM, 0.15 μM, 0.38 μM for GRK1, GRK2, GRK5, respectively.
|
-
ACS Omega, 2024, 9(37):38477-38489
|
|
| E2817 |
GRK5-IN-2
|
GRK5-IN-2 is a potent G-protein-coupled receptor kinase 5 (GRK5) inhibitor.
|
|
|